RT Journal Article SR Electronic T1 Genetic Profiling of α1-Adrenergic Receptor Subtypes by Oligonucleotide Microarrays: Coupling to Interleukin-6 Secretion but Differences in STAT3 Phosphorylation and gp-130 JF Molecular Pharmacology JO Mol Pharmacol FD American Society for Pharmacology and Experimental Therapeutics SP 1104 OP 1116 DO 10.1124/mol.63.5.1104 VO 63 IS 5 A1 Pedro J. Gonzalez-Cabrera A1 Robert J. Gaivin A1 June Yun A1 Sean A. Ross A1 Robert S. Papay A1 Dan F. McCune A1 Boyd R. Rorabaugh A1 Dianne M. Perez YR 2003 UL http://molpharm.aspetjournals.org/content/63/5/1104.abstract AB α1-Adrenoceptor subtypes (α1A-, α1B-, α1D-) are known to couple to similar signaling pathways, although differences among the subtypes do exist. As a more sensitive assay, we used oligonucleotide microarrays to identify gene expression changes in Rat-1 fibroblasts stably expressing each individual subtype. We report the gene expressions that change by at least a factor of 2 or more. Gene expression profiles significantly changed equally among all three subtypes, despite the unequal efficacy of the inositol phosphate response. Gene expressions were clustered into cytokines/growth factors, transcription factors, enzymes, and extracellular matrix proteins. There were also a number of individual subtype-specific changes in gene expression, suggesting a link to independent pathways. In addition, all three α1-AR subtypes robustly stimulated the transcription of the prohypertrophic cytokine interleukin (IL)-6, but differentially altered members of the IL-6 signaling pathway (gp-130 and STAT3). This was confirmed by measurement of secreted IL-6, activated STAT3, and gp-130 levels. Activation of STAT3 Tyr705 phosphorylation by the α1-ARs was not through IL-6 activation but was synergistic with IL-6, suggesting direct effects. Interestingly, α1B-AR stimulation caused the dimerization-dependent phosphorylation of Tyr705 on STAT3 but did not activate the transcriptional-dependent phosphorylation of Ser727. The α1B-AR also constitutively down-regulated the protein levels of gp-130. These results suggest that the α1B-AR has differential effects on the phosphorylation status of the STAT3 pathway and may not be as prohypertrophic as the other two subtypes. The American Society for Pharmacology and Experimental Therapeutics